- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03659812
Magnetic Activated Cell Sorting in Artificial Insemination With Donor Sperm (MACSIAD)
September 5, 2018 updated by: IVI Sevilla
Application of Magnetic Activated Cell Sorting (MACS) of Spermatozoa in Artificial Insemination Cycles With Donor Sperm (AID)
The aim of this study is to analyse the efficacy of MACS technique for the selection of spermatozoa and its effects on implantation, pregnancy and miscarriage rate.
This study will be performed by two IVI clinics (IVI Sevilla and IVI Madrid) with the purpose of finding new techniques that allow us to better select spermatozoa and improve the results of assisted reproduction techniques.
Study Overview
Study Type
Interventional
Enrollment (Actual)
130
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sevilla, Spain, 41011
- IVI Sevilla
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women who undergo artificial insemination with donor sperm
- Signing an informed consent form to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: MACS is applied to the sperm sample
Previous to the AID technique, the sperm sample undergoes capacitation through Percoll density gradient and MACS
|
MACS is a technique that allow us to tag and detect apoptotic spermatozoa.
These apoptotic spermatozoa have phosphatidylserine in their membranes, so we add magnetic beads with Annexin V, which binds specifically to phosphatidylserine.
The spermatozoa are then tagged and can be retained in a magnetic field, allowing us to collect just the non-apoptotic spermatozoa.
|
|
NO_INTERVENTION: MACS is not applied to the sperm sample
Previous to the AID technique, MACS only undergoes capacitation through Percoll density gradient, but not MACS technique
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pregnancy rate
Time Frame: Ultrasound examination is performed 5 weeks after artificial insemination. Pregnancy rate is calculated during the phase of data analysis.
|
The number of pregnancies confirmed by ultrasound divided by the number of artificial insemination cycles.
Pregnancy is confirmed by ultrasound examination.
|
Ultrasound examination is performed 5 weeks after artificial insemination. Pregnancy rate is calculated during the phase of data analysis.
|
|
Implantation rate
Time Frame: The beta hCG analysis is performed 15 days after artificial insemination. Implantation rate is calculated during the phase of data analysis.
|
The number of positive results of beta human chorionic gonadotropin (hCG) test divided by the number of artificial insemination cycles.
Implantation is confirmed through the analysis of beta hCG in blood.
|
The beta hCG analysis is performed 15 days after artificial insemination. Implantation rate is calculated during the phase of data analysis.
|
|
Live birth rate
Time Frame: Live births are assessed at delivery (end of pregnancy period). Live birth rate is calculated during the phase of data analysis
|
The number of live births divided by the number of artificial insemination cycles
|
Live births are assessed at delivery (end of pregnancy period). Live birth rate is calculated during the phase of data analysis
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sperm cell concentration
Time Frame: This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
|
Concentration of sperm cells in sperm sample before and after applying the MACS technique
|
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
|
|
Sperm cell motility
Time Frame: This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
|
Proportion of sperm cells with progressive motility (according to World Health Organisation 2010 criteria) before and after applying the MACS technique
|
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
|
|
Sperm cell morphology
Time Frame: This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
|
Proportion of sperm cells with normal morphology (according to World Health Organisation 2010 criteria) before and after applying the MACS technique
|
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
|
|
Sperm cells vitality
Time Frame: This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
|
Proportion of live sperm cells before and after applying the MACS technique
|
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
|
|
Sperm sample volume
Time Frame: This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
|
The volume of sperm obtained after masturbation
|
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 7, 2017
Primary Completion (ACTUAL)
February 16, 2018
Study Completion (ACTUAL)
April 13, 2018
Study Registration Dates
First Submitted
April 24, 2018
First Submitted That Met QC Criteria
September 5, 2018
First Posted (ACTUAL)
September 6, 2018
Study Record Updates
Last Update Posted (ACTUAL)
September 6, 2018
Last Update Submitted That Met QC Criteria
September 5, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IVISEV-006-IAD
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Viable BiosciencesEnrolling by invitationInfertility (IVF Patients) | Infertility Assisted Reproductive TechnologyUnited States
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
Clinical Trials on MACS technique
-
IVI SevillaTerminatedMACS Technique EfficacySpain
-
IVI MadridTerminatedBlastocyst Time | Pronuclear Appearance | Pronuclear Fading | Embryo Compaction | Cleavage TimesSpain
-
Levita MagneticsRecruitingPlastic Surgery ProceduresChile
-
Access Business GroupCompletedGut MicrobiomeUnited States
-
Ganin Fertility CenterThe Cleveland Clinic; University of the Western CapeCompletedSperm DNA FragmentationEgypt
-
University of MinnesotaCompletedSarcopenia | Dysbiosis | Colon CancerUnited States
-
Ganin Fertility CenterCompletedInfertility | Sperm DNA FragmentationEgypt
-
Butler HospitalNational Institute of Mental Health (NIMH)Completed
-
Instituto de Investigación Sanitaria y Biomédica...Completed
-
Ganin Fertility CenterThe Cleveland Clinic; University of the Western CapeCompletedGender Ratio of ICSI OutcomeEgypt